CORMORANT ASSET MANAGEMENT, LP – SPDR S&P Biotech ETF Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$0
portfolio value
SPDR S&P Biotech ETF 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | call | Decrease | -100.00% | -450K shares | -33.42M | $79.32 | 0 |
| Q2 2022 | call | Increase | 0.00% | 450K shares | 33.42M | $74.27 | 450K |
| Q2 2021 | put | Decrease | -100.00% | -1M shares | -135.65M | $135.4 | 0 |
| Q1 2021 | put | Decrease | -33.33% | -500K shares | -75.52M | $135.65 | 1M |
| Q4 2020 | put | Increase | +200.00% | 1M shares | 155.45M | $140.74 | 1.5M |
| Q3 2020 | put | 0.00% | 0 shares | -260K | $111.27 | 500K | |
| Q2 2020 | put | Increase | 0.00% | 500K shares | 55.97M | $111.7 | 500K |
| Q1 2020 | put | Decrease | -100.00% | -500K shares | -47.55M | $77.26 | 0 |
| Q4 2019 | put | Increase | +25.00% | 100K shares | 17.05M | $94.88 | 500K |
| Q3 2019 | put | Decrease | -55.56% | -500K shares | -48.43M | $76.07 | 400K |
| Q2 2019 | put | Decrease | -2.70% | -25K shares | -4.81M | $87.5 | 900K |
| Q1 2019 | put | Increase | 0.00% | 925K shares | 83.75M | $90.32 | 925K |